A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
This study retrospectively reviews the susceptibility of 135 baseline ICU candidemia isolates (from 1997 to 2007) to nine antifungals as determined by the AFST-EUCAST microdilution method and identifies the most frequent causative agents of confirmed point-source candidemia outbreaks in local intensive care units. A minority of common and rare Candida species displayed decreased susceptibility to all antifungals.
Dimopoulos
George
G
Department of Critical Care, University Hospital Attikon, Medical School, National and Kapodistrian Univeristy of Athens, Athens, Greece.
Velegraki
Aristea
A
Falagas
Matthew E
ME
D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002175:Candida / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D002177:Candidiasis / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology* / Q000382:microbiology; D003625:Data Collection; D004198:Disease Susceptibility; D006115:Greece / Q000453:epidemiology; D006801:Humans; D007362:Intensive Care Units; D008826:Microbial Sensitivity Tests / Q000379:methods; D012189:Retrospective Studies
D000935:Antifungal Agents